Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands

British Journal of Dermatology

Volumn 165, Issue 4, 2011, Pages 874-881

  Flohil, S C ^a   Koljenovic S ^b   De Haas, E R M ^a   Overbeek, L I H ^c   De Vries, E ^a,d   Nijsten, T ^a  

^a Departments of Dermatology   (Netherlands)

^b Erasmus MC Cancer Institute   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d PALGA   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; CYTOPATHOLOGY; FEMALE; FOLLOW UP; GENDER; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; SENESCENCE; SEX RATIO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; FEMALE; FOLLOW-UP STUDIES; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; NETHERLANDS; RISK FACTORS; SKIN NEOPLASMS; YOUNG ADULT;

EID: 80053532099     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10488.x     Document Type: Article

References (29)

1. Holterhues C, Vries E, Louwman MW, et al. Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005. J Invest Dermatol 2010; 130: 1807-12.
2. Bath-Hextall F, Leonardi-Bee J, Smith C, et al. Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. Int J Cancer 2007; 121: 2105-8. (Pubitemid 47463176)
3. Birch-Johansen F, Jensen A, Mortensen L, et al. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: rapid incidence increase among young Danish women. Int J Cancer 2010; 127: 2190-8.
4. Flohil SC, de Vries E, Neumann HAM, et al. Incidence, prevalence, and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm Venereol 2011; 91: 24-30.
5. Nederlandse Vereniging voor Dermatologie en Venereologie. Basaalcelcarcinoom. Available at: (last accessed 31 July 2011).
6. Telfer NR, Colver GB, Morton CA,. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35-48. (Pubitemid 351874512)
7. Hauschild A, Breuninger H, Kaufmann R, et al. Short German guidelines: basal cell carcinoma. J Dtsch Dermatol Ges 2008; 6 (Suppl. 1): S2-4. (Pubitemid 351782282)
8. National Comprehensive Cancer Network. NCCN Guidelines. Available at: (last accessed 31 July 2011).
9. Cancer Council Australia. Basal Cell Carcinoma, Squamous Cell Carcinoma (and Related Lesions)-a Guide to Clinical Management in Australia. Available at: (last accessed 31 July 2011).
10. Fields RC, Coit DG,. Evidence-based follow-up for the patient with melanoma. Surg Oncol Clin N Am 2011; 20: 181-200.
11. Milan T, Pukkala E, Verkasalo PK, et al. Subsequent primary cancers after basal-cell carcinoma: a nationwide study in Finland from 1953 to 1995. Int J Cancer 2000; 87: 283-8. (Pubitemid 30434359)
12. Karagas MR, Greenberg ER, Mott LA, et al. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Cancer Epidemiol Biomarkers Prev 1998; 7: 157-61. (Pubitemid 28109848)
13. Levi F, La Vecchia C, Te VC, et al. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 1998; 147: 722-6. (Pubitemid 28183271)
14. Marcil I, Stern RS,. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 2000; 136: 1524-30. (Pubitemid 32009273)
15. Kiiski V, de Vries E, Flohil SC, et al. Risk factors for single and multiple basal cell carcinomas. Arch Dermatol 2011; 146: 848-55.
16. Richmond-Sinclair NM, Pandeya N, Ware RS, et al. Incidence of basal cell carcinoma multiplicity and detailed anatomic distribution: longitudinal study of an Australian population. J Invest Dermatol 2009; 129: 323-8.
17. Richmond-Sinclair NM, Pandeya N, Williams GM, et al. Clinical signs of photodamage are associated with basal cell carcinoma multiplicity and site: a 16-year longitudinal study. Int J Cancer 2010; 127: 2622-9.
18. Casparie M, Tiebosch AT, Burger G, et al. Pathology databanking and biobanking in the Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 2007; 29: 19-24. (Pubitemid 46535194)
19. de Vries E, Nijsten T, Louwman MW, et al. [Skin cancer epidemic in the Netherlands]. Ned Tijdschr Geneeskd 2009; 153: A768.
20. Pandeya N, Purdie DM, Green A, et al. Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: follow-up data from the Nambour Skin Cancer Prevention Trial. Am J Epidemiol 2005; 161: 748-54.
21. Karagas MR, Stukel TA, Greenberg ER, et al. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. JAMA 1992; 267: 3305-10.
22. Bruynzeel I, Bergman W, Hartevelt HM, et al. 'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer. Br J Dermatol 1991; 124: 49-55.
23. Katz KA, Marcil I, Stern RS,. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet A light-treated psoriasis patients. J Invest Dermatol 2002; 118: 1038-43. (Pubitemid 34639184)
24. Wisgerhof HC, Edelbroek JR, de Fijter JW, et al. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors. Transplantation 2010; 89: 1231-8.
25. Steele RJ, Kostourou I, McClements P, et al. Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening. BMJ 2010; 341: c5531.
26. Scrivener Y, Grosshans E, Cribier B,. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 2002; 147: 41-7. (Pubitemid 34779436)
27. Arits A, Schlangen M, Nelemans P, et al. Trends in the incidence of basal cell carcinoma by histopathological subtype. J Eur Acad Dermatol Venereol 2011; 25: 565-9.
28. van Iersel CA, van de Velden HV, Kusters CD, et al. Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up. Br J Dermatol 2005; 153: 1078-80. (Pubitemid 41540790)
29. de Vries E, Steliarova-Foucher E, Spatz A, et al. Skin cancer incidence and survival in European children and adolescents (1978-1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006; 42: 2170-82. (Pubitemid 44224066)